Abcellera Biologics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ABCL and other ETFs, options, and stocks.About ABCL
AbCellera Biologics, Inc. engages in the development of therapeutic antibodies. It offers antibody discovery platform that searches, decodes and analyzes natural immune systems to find antibodies that can be developed to prevent and treat disease.
CEOCarl Lars G. Hansen
CEOCarl Lars G. Hansen
Employees586
Employees586
HeadquartersVancouver, British Columbia
HeadquartersVancouver, British Columbia
Founded2012
Founded2012
Employees586
Employees586
ABCL Key Statistics
Market cap1.19B
Market cap1.19B
Price-Earnings ratio-7.96
Price-Earnings ratio-7.96
Dividend yield—
Dividend yield—
Average volume1.53M
Average volume1.53M
High today$4.20
High today$4.20
Low today$3.86
Low today$3.86
Open price$3.92
Open price$3.92
Volume2.20M
Volume2.20M
52 Week high$8.05
52 Week high$8.05
52 Week low$3.62
52 Week low$3.62
ABCL News
Yahoo Finance 2d
Insider Stock Buying Reaches US$1.61m On AbCellera Biologics - Yahoo FinanceQuite a few insiders have dramatically grown their holdings in AbCellera Biologics Inc. (NASDAQ:ABCL) over the past 12 months. An insider's optimism about the c...
Yahoo Finance 4d
Analysts Estimate AbCellera Biologics Inc. to Report a Decline in Earnings: What to Look Out for - Yahoo FinanceAbCellera Biologics Inc. (ABCL) is expected to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended Marc...
Analyst ratings
100%
of 9 ratingsBuy
100%
Hold
0%
Sell
0%